NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE: ENZ) announced today that its Enzo Clinical Labs division has become one of the first diagnostic laboratories to make available a rapid and sensitive H1N1 PCR test for the swine flu virus. Enzo Clinical Labs serves physicians throughout the Metropolitan New York area, as well as New Jersey and parts of Pennsylvania.
